Key result
The anterior mitral leaflet length to left ventricular end-systolic dimension ratio independently predicted left ventricular outflow tract obstruction in hypertrophic cardiomyopathy with an AUC of 0.71.
Why the study?
Do specific echocardiographic morphological variables predict left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy?
Observational (n=50)
No
Do specific echocardiographic morphological variables predict left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy?
Effect estimate: AUC 0.71 (95% CI 0.55-0.87)
p-value: p=<0.05
The ratio of anterior mitral leaflet length to end-systolic left ventricular dimension is a strong independent echocardiographic predictor of left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy.
May aid echocardiographic risk stratification in hypertrophic cardiomyopathy; leaves open prospective validation before clinical adoption.
The morphological determinants of left ventricular outflow tract (LVOT) obstruction in hypertrophic cardiomyopathy (HCM) are not completely understood. We aimed to identify the anatomical risks of the obstruction using echocardiography.Fifty patients with untreated HCM were classified into two groups: those with LVOT pressure gradient (LVOTPG) ≥ 30 mmHg (obstructive HCM [HOCM] group) and those with LVOTPG < 30 mmHg (HNCM group). The echocardiographic morphological variables were analyzed to determine whether they were predictive of LVOT obstruction. Systolic anterior motions of the mitral valve were observed in 100% of patients in the HOCM group but only in 58% in the HNCM group. There were no significant differences in wall thickness, end-systolic LV dimension (LVDs), or LVOT diameter between the two groups. However, HOCM subjects had a shorter distance from papillary muscles to the inter-ventricular septum (5.97 ± 2.3 versus 9.20 ± 1.9 mm, respectively, P < 0.0001) and a longer anterior mitral leaflet (AML) length (24.7 ± 5.8 versus 20.1 ± 5.4 mm, respectively, P < 0.01) compared to the HNCM group. The AML length/LVDs ratio was significantly higher in the HOCM group compared to the HNCM group (1.02 ± 0.34 versus 0.78 ± 0.26, P < 0.01), and an LVOT obstruction was predicted with an area under the curve of 0.71 (P < 0.05). Multiple linear regression revealed that only the AML length/LVDs ratio was independently associated with LVOTPG (P < 0.01).The AML length/LVDs ratio has a significant predictive value for LVOT obstruction and a strong relationship with LVOTPGs. The AML length/LVDs ratio determines the anatomical risk of LVOT obstruction in HCM.
No takes yet. Share an insight, caveat, or question.
Nara et al. (2018) conducted an observational in Hypertrophic cardiomyopathy (n=50). Obstructive hypertrophic cardiomyopathy (LVOTPG ≥ 30 mmHg) vs. Non-obstructive hypertrophic cardiomyopathy (LVOTPG < 30 mmHg) was evaluated on Prediction of left ventricular outflow tract (LVOT) obstruction using the anterior mitral leaflet length to left ventricular end-systolic dimension (AML length/LVDs) ratio (AUC 0.71, 95% CI 0.55-0.87, p=<0.05). The anterior mitral leaflet length to left ventricular end-systolic dimension ratio independently predicted left ventricular outflow tract obstruction in hypertrophic cardiomyopathy with an AUC of 0.71.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: